{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/LABT",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Lakewood-Amedex Biotherapeutics Inc., listed on NASDAQ under the ticker LABT. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Nevada. The segment is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 42 filings in the twelve months to 2026-11-08, across 32 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-09-29, an agm_egm filing, and is 40 days before the record date. The exchange median for NASDAQ is 6.0 days of cadence, 52 filings and 5.0 days of latency across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 6.0 days of cadence, 63.0 filings and 4.0 days of latency across 526 issuers. The filings by type are: 16 prospectus, 11 regulatory_filing, 6 directors_dealings, 4 agm_egm, 2 results, 1 ad_hoc, 1 corporate_news and 1 director_change.\n\n## Auditor\n\nThe auditor of record is not on the record, and its location is not on the record. The latest annual report cover carries no dei:AuditorName tag, as foreign private issuers and older filings carry none. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds two listing lines, dated 2026-04-17 and 2026-04-22. No delisting and no name change are on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's sealed years are 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://data.sec.gov/submissions/CIK0002079272.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/LABT (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/LABT (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/LABT",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://scr.zacks.com/news/news-details/2026/LABT--Initiating-Coverage-of-Lakewood-Amedex-Building-a-Next-Generation-Antimicrobial-Platform/default.aspx",
     "result": "an aggregator or news site — not a research note"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "agm_egm": 4,
    "corporate_news": 1,
    "director_change": 1,
    "directors_dealings": 6,
    "prospectus": 16,
    "regulatory_filing": 11,
    "results": 2
   },
   "cadence_median_gap_days": 5,
   "filing_days": 32,
   "filings": 42,
   "latency_days": 40,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-09-29",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026104177/ea0306660-8k_lakewood.htm",
     "title": "8-K — CURRENT REPORT (items 5.07)",
     "type": "agm_egm"
    },
    {
     "category": "EFFECT",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/999999999526003056/xslEFFECTX01/primary_doc.xml",
     "title": "EFFECT (items ,,)",
     "type": "regulatory_filing"
    },
    {
     "category": "S-1",
     "date": "2026-09-18",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026101512/ea0305803-s1_lakewood.htm",
     "title": "S-1 — REGISTRATION STATEMENT",
     "type": "prospectus"
    },
    {
     "category": "DRS",
     "date": "2026-08-24",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026092773/filename1.htm",
     "title": "DRS",
     "type": "regulatory_filing"
    },
    {
     "category": "424B3",
     "date": "2026-08-17",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026090808/ea0302397-424b3_lakewood.htm",
     "title": "424B3 — PROSPECTUS SUPPLEMENT",
     "type": "prospectus"
    }
   ],
   "latest_filing_date": "2026-09-29",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/LABT",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "market": "US",
    "reason": "no LEI, so no GLEIF ISIN route; EDGAR carries no ISIN",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0002079272.json",
    "state": "sourced",
    "value": "United States — Nevada"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-NV",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0002079272.json",
    "state": "sourced",
    "value": "Lakewood-Amedex Biotherapeutics Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0002079272.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0002079272.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "LABT"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [
    {
     "date": "2026-04-17",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026045037/ea0286678-8a12b_lakewood.htm",
     "title": "8-A12B — FOR REGISTRATION OF CERTAIN CLASSES"
    },
    {
     "date": "2026-04-22",
     "source": "https://www.sec.gov/Archives/edgar/data/2079272/000135445726000363/LABT_8A_Cert_0002079272.pdf",
     "title": "CERT"
    }
   ],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:175a0b4b9e6c0929615f6ad853f7b396f92350e0091c2a4c7d369ca1124a424e",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/LABT",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:175a0b4b9e6c0929615f6ad853f7b396f92350e0091c2a4c7d369ca1124a424e",
 "path": "/us/NASDAQ/LABT",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Lakewood-Amedex Biotherapeutics Inc., listed on NASDAQ under the ticker LABT. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Nevada. The segment is not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 42 filings in the twelve months to 2026-11-08, across 32 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-09-29, an agm_egm filing, and is 40 days before the record date. The exchange median for NASDAQ is 6.0 days of cadence, 52 filings and 5.0 days of latency across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 6.0 days of cadence, 63.0 filings and 4.0 days of latency across 526 issuers. The filings by type are: 16 prospectus, 11 regulatory_filing, 6 directors_dealings, 4 agm_egm, 2 results, 1 ad_hoc, 1 corporate_news and 1 director_change.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and its location is not on the record. The latest annual report cover carries no dei:AuditorName tag, as foreign private issuers and older filings carry none. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds two listing lines, dated 2026-04-17 and 2026-04-22. No delisting and no name change are on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's sealed years are 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0002079272.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/LABT"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/LABT"
  }
 ],
 "title": "Lakewood-Amedex Biotherapeutics Inc. (LABT) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}